Pediatric Asthma Study Using Stepwise Treatment With Two Food And Drug Administration Approved Asthma Medications
Нормализованный состав
fluticasone
salmeterol
fluticasone propionate combination product
Завершено
Первоисточник ↗
Информация
Результаты не размещены (факт источника)
Информация
Связь с регистрацией не подтверждена
Факт источника
Основные сведения
- Компания / организация
- GlaxoSmithKline
- Протокол
- SER9702/CATO
- Фаза
- PHASE3
- Статус
- Завершено
- Дата начала
- 30.11.1999
- Дата завершения
- —
- Участники
- 200
- Результаты
- Не найдены
Нормализация
Исходный и нормализованный состав
Факт источника
Salmeterol + Fluticasone propionate combination product + Fluticasone propionate
Значение сохранено без подмены исходного факта.
Нормализованное значение
fluticasone
salmeterol
fluticasone propionate combination product
Используется для поиска, сравнения и связывания.
Связи
Кандидатные связи
История
Изменения относительно загрузок
details{'conditions': ['Asthma'], 'countries': ['Netherlands'], 'interventions': [{'name': 'Salmeterol/Fluticasone propionate combination product', 'type': 'DRUG', 'description': None}, {'name': 'Fluticasone propionate', 'type': 'DRUG', 'description': None}], 'sponsors': [{'name': 'GlaxoSmithKline', 'role': 'lead', 'agency_class': 'INDUSTRY'}], 'facilities': [{'zip': '1815 JD', 'city': 'Alkmaar', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '1315 RA', 'city': 'Almere Stad', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '1081 HV', 'city': 'Amsterdam', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '1105 AZ', 'city': 'Amsterdam', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '4818 CK', 'city': 'Breda', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '5623 EJ', 'city': 'Eindhoven', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '9713 GZ', 'city': 'Groningen', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '1213 VX', 'city': 'Hilversum', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '2333 ZA', 'city': 'Leiden', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '6229 HX', 'city': 'Maastricht', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '3015 GD', 'city': 'Rotterdam', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '6131 BK', 'city': 'Sittard', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '2566 MJ', 'city': 'The Hague', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '3584 EA', 'city': 'Utrecht', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '5504 DB', 'city': 'Veldhoven', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '8011 JW', 'city': 'Zwolle', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}], 'outcomes': [], 'brief_summary': 'This study was designed to evaluate if, in children with asthma, a stepwise treatment (five levels varying from once daily fluticasone propionate 100mcg until twice daily a fixed combination of salmeterol and fluticasone propionate 50/500 mcg) based on symptom scores alone results in a sub-optimal treatment when compared to treatment based on cumulative symptom scores and bronchial hyperresponsiveness (PD20 methacholine).', 'study_type': 'INTERVENTIONAL', 'source_organization': 'GlaxoSmithKline', 'results_first_posted_date': None, 'has_results_basis': 'results_first_posted_date'}→{'conditions': ['Asthma'], 'countries': ['Netherlands'], 'interventions': [{'name': 'Salmeterol/Fluticasone propionate combination product', 'type': 'DRUG', 'description': None, 'other_names': [], 'design_groups': []}, {'name': 'Fluticasone propionate', 'type': 'DRUG', 'description': None, 'other_names': ['Salmeterol/Fluticasone propionate combination product'], 'design_groups': []}], 'composition_semantics': 'study_intervention_labels_not_product_formula', 'sponsors': [{'name': 'GlaxoSmithKline', 'role': 'lead', 'agency_class': 'INDUSTRY'}], 'facilities': [{'zip': '1815 JD', 'city': 'Alkmaar', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '1315 RA', 'city': 'Almere Stad', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '1081 HV', 'city': 'Amsterdam', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '1105 AZ', 'city': 'Amsterdam', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '4818 CK', 'city': 'Breda', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '5623 EJ', 'city': 'Eindhoven', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '9713 GZ', 'city': 'Groningen', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '1213 VX', 'city': 'Hilversum', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '2333 ZA', 'city': 'Leiden', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '6229 HX', 'city': 'Maastricht', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '3015 GD', 'city': 'Rotterdam', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '6131 BK', 'city': 'Sittard', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '2566 MJ', 'city': 'The Hague', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '3584 EA', 'city': 'Utrecht', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '5504 DB', 'city': 'Veldhoven', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}, {'zip': '8011 JW', 'city': 'Zwolle', 'name': 'GSK Investigational Site', 'state': None, 'country': 'Netherlands'}], 'outcomes': [], 'brief_summary': 'This study was designed to evaluate if, in children with asthma, a stepwise treatment (five levels varying from once daily fluticasone propionate 100mcg until twice daily a fixed combination of salmeterol and fluticasone propionate 50/500 mcg) based on symptom scores alone results in a sub-optimal treatment when compared to treatment based on cumulative symptom scores and bronchial hyperresponsiveness (PD20 methacholine).', 'study_type': 'INTERVENTIONAL', 'source_organization': 'GlaxoSmithKline', 'results_first_posted_date': None, 'has_results_basis': 'results_first_posted_date', 'start_date_type': None, 'start_month_year': '1999-11', 'start_date_precision': 'month', 'completion_date_type': None, 'completion_month_year': None, 'completion_date_precision': None, 'primary_completion_date': None, 'primary_completion_month_year': None, 'primary_completion_date_precision': None, 'primary_completion_date_type': None, 'intervention_component_groups': [['salmeterol', 'unmapped:fluticasone-propionate-combination-product'], ['fluticasone']], 'intervention_normalization': [{'name': 'Salmeterol/Fluticasone propionate combination product', 'selected_label': 'Salmeterol/Fluticasone propionate combination product', 'selection_basis': 'primary_label', 'role': 'study_intervention', 'components': ['salmeterol', 'unmapped:fluticasone-propionate-combination-product'], 'unverified_label_components': ['unmapped:fluticasone-propionate-combination-product'], 'items': [{'original': 'Salmeterol', 'component': 'salmeterol', 'status': 'resolved', 'method': 'versioned_lexicon'}, {'original': 'Fluticasone propionate combination product', 'component': 'unmapped:fluticasone-propionate-combination-product', 'status': 'unresolved', 'method': 'no_verified_mapping'}], 'excluded_accessory_parts': [], 'verified_other_name_component_sets': []}, {'name': 'Fluticasone propionate', 'selected_label': 'Fluticasone propionate', 'selection_basis': 'primary_label', 'role': 'study_intervention', 'components': ['fluticasone'], 'unverified_label_components': [], 'items': [{'original': 'Fluticasone propionate', 'component': 'fluticasone', 'status': 'resolved', 'method': 'versioned_lexicon'}], 'excluded_accessory_parts': [], 'verified_other_name_component_sets': []}]}